<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Fig" xml:lang="en" id="bjh17168-fig-0001" orientation="portrait" position="float">
 <label>Fig 1</label>
 <caption>
  <p>This flow diagram illustrates the progress through the various phases of the CARDAMON phase II clinical trial, including the impact of COVID‐19 on the 70 patients on maintenance K across the two treatment arms at the start of the lockdown period. The 15 patients who stopped K maintenance joined the 170 patients who were already on long‐term follow‐up on 24 March 2020, bringing the number up to a total of 185. SCT, stem cell transplantation; K, carfilzomib; C, cyclophosphamide; d, dexamethasone.</p>
 </caption>
 <graphic id="nlm-graphic-1" xlink:href="BJH-192-e14-g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
